Drugs / Diprosis
last change Sep 2015 re-read 2 minutes ago

Diprosis

Developed for
psoriasis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02432027 Comparator Jun → Aug 2015 psoriasis Prism Pharma Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Diprosis ClinicalTrials.gov intervention name — accepted as the source's own label NCT02432027